Synthesis and Initial In Vivo Evaluation of [11C]AZ683-A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R)

被引:24
|
作者
Tanzey, Sean S. [1 ]
Shao, Xia [2 ]
Stauff, Jenelle [2 ]
Arteaga, Janna [2 ]
Sherman, Phillip [2 ]
Scott, Peter J. H. [1 ,2 ]
Mossine, Andrew, V [2 ]
机构
[1] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA
关键词
neuroinflammation; microglia; carbon-11; radiochemistry; positron emission tomography; CSF-1R INHIBITOR; MICROGLIA; PREVENTS; TSPO; 3-AMIDO-4-ANILINOQUINOLINES; NEUROINFLAMMATION; JNJ-40346527; DISEASE; CANCER; MODEL;
D O I
10.3390/ph11040136
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Positron emission tomography (PET) imaging of Colony Stimulating Factor 1 Receptor (CSF1R) is a new strategy for quantifying both neuroinflammation and inflammation in the periphery since CSF1R is expressed on microglia and macrophages. AZ683 has high affinity for CSF1R (K-i = 8 nM; IC50 = 6 nM) and >250-fold selectivity over 95 other kinases. In this paper, we report the radiosynthesis of [C-11]AZ683 and initial evaluation of its use in CSF1R PET. [C-11]AZ683 was synthesized by C-11-methylation of the desmethyl precursor with [C-11]MeOTf in 3.0% non-corrected activity yield (based upon [C-11]MeOTf, >99% radiochemical purity and high molar activity. Preliminary PET imaging with [C-11]AZ683 revealed low brain uptake in rodents and nonhuman primates, suggesting that imaging neuroinflammation could be challenging but that the radiopharmaceutical could still be useful for peripheral imaging of inflammation.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Aging-related inflammatory and metabolic disorder in the novel mutation of colony-stimulating factor-1 receptor (csf1r)P853T/+ in CSF1R-microglial encephalopathy
    Wang, Xiaohong
    Wang, Yanli
    Jiang, Tianlin
    Jiang, Jiwei
    Wang, Linlin
    Yang, Shiyi
    Sun, Mengfan
    Zhang, Yuan
    Jia, Ziyan
    Li, Wenyi
    Ren, Qiwei
    Zhang, Cuicui
    Liu, Jianjian
    Zhu, Yinwei
    Zhao, Min
    Jiang, Shirui
    Zhang, Huiying
    Chen, Jinglong
    Xu, Jun
    GENES & DISEASES, 2025, 12 (02)
  • [32] Blocking colony stimulating factor 1 receptor (CSF1R) improves anti-tumor effects of adoptive T cell transfer therapy
    Mok, Stephen
    Tsui, Christopher
    Xu, Jingying
    Comin-Anduix, Begonya
    Chodon, Thinle
    Ribas, Antoni
    Koya, Richard C.
    CANCER RESEARCH, 2013, 73 (08)
  • [33] Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
    Cheng, Baoying
    Li, Xin
    Dai, Kai
    Duan, Shengshun
    Rong, Zhouyi
    Chen, Yingmin
    Lu, Liangcheng
    Liu, Zhaoji
    Huang, Xiaohua
    Xu, Huaxi
    Zhang, Yun-Wu
    Zheng, Honghua
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
    Juan Garcia Valero
    Alba Matas-Céspedes
    Fabián Arenas
    Vanina Rodriguez
    Joaquim Carreras
    Neus Serrat
    Martina Guerrero-Hernández
    Anella Yahiaoui
    Olga Balagué
    Silvia Martin
    Cristina Capdevila
    Lluis Hernández
    Laura Magnano
    Alfredo Rivas-Delgado
    Stacey Tannheimer
    Maria C. Cid
    Elías Campo
    Armando López-Guillermo
    Dolors Colomer
    Patricia Pérez-Galán
    Leukemia, 2021, 35 : 2635 - 2649
  • [35] The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
    Valero, Juan Garcia
    Matas-Cespedes, Alba
    Arenas, Fabian
    Rodriguez, Vanina
    Carreras, Joaquim
    Serrat, Neus
    Guerrero-Hernandez, Martina
    Yahiaoui, Anella
    Balague, Olga
    Martin, Silvia
    Capdevila, Cristina
    Hernandez, Lluis
    Magnano, Laura
    Rivas-Delgado, Alfredo
    Tannheimer, Stacey
    Cid, Maria C.
    Campo, Elias
    Lopez-Guillermo, Armando
    Colomer, Dolors
    Perez-Galan, Patricia
    LEUKEMIA, 2021, 35 (09) : 2635 - 2649
  • [36] SYHA1813, a vascular endothelial growth factor receptor (VEGFR) 1-3/colony-stimulating factor 1 receptor (CSF1R) inhibitor, in patients with recurrent glioblastoma
    Li, W.
    Kang, Z.
    Chen, F.
    Li, S.
    Zhang, B.
    Huang, M.
    Yang, X.
    She, F.
    Xiang, S.
    Liu, G.
    Liu, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S408 - S408
  • [37] Cloning and expression of porcine Colony Stimulating Factor-1 (CSF-1) and Colony Stimulating Factor-1 Receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34
    Gow, Deborah J.
    Garceau, Valerie
    Kapetanovic, Ronan
    Sester, David P.
    Fici, Greg J.
    Shelly, John A.
    Wilson, Thomas L.
    Hume, David A.
    CYTOKINE, 2012, 60 (03) : 793 - 805
  • [38] Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice
    Wang, YQ
    Berezovska, O
    Fedoroff, S
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 57 (05) : 616 - 632
  • [39] A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers
    Bendell, Johanna C.
    Tolcher, Anthony W.
    Jones, Suzanne F.
    Beeram, Muralidhar
    Infante, Jeffrey R.
    Larsen, Paul
    Rasor, Kevin
    Garrus, Jennifer E.
    Li, Jinfang
    Cable, P. Louann
    Eberhardt, Christine
    Schreiber, Jennifer
    Rush, Selena
    Wood, Kenneth W.
    Barret, Emma
    Patnaik, Amita
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [40] Role of the Colony-Stimulator Factor-1 Receptor (CSF1R) T-cell Lymphoma Progression
    Murga-Zamalloa, Carlos
    Polka, Avery
    Brown, Noah
    Bailey, Nathaniel
    Wilcox, Ryan
    MODERN PATHOLOGY, 2017, 30 : 364A - 364A